Treatment of peri-implantitis with allografts and enamel proteins
- Conditions
- Oral HealthPeri-implantitis
- Registration Number
- ISRCTN15000657
- Lead Sponsor
- Arrow Development S.L.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 40
1. Age =18 years
2. Peri-implant bone defect =3 mm assessed radiographically
3. PPD =5 mm combined with bleeding on probing or suppuration
4. Intra-surgically, bone defect must have at least an intraosseous component of 3 mm and a width of no more than 4 mm
5. Implants =1 year in function
1. Treated for peri-implantitis during the previous 6 months
2. Intake of systemic or local antibiotics during the previous 6 months
3. Pregnant patients
4. Systemically unhealthy patients
5. Patients allergic to collagen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment success will be defined as the absence of bleeding on probing (BoP)/pus, probing pocket depth (PPD) =5 mm and =1 mm recession (measured using Periodontal Manual probe CP 15 Hu-Friedy) at 4, 12, 24 and 48 weeks after surgical therapy
- Secondary Outcome Measures
Name Time Method